Pharmaceutical Economics begins with an investigation of the structure of the industry and its three main components: the research firms which produce innovative products; the generic drug industry and its expanding role; and the biotech industry, which is regarded as the future for pharmaceuticals. Further sections discuss topics including demand and incentives, pricing and regulation.
Elgar Research Reviews in Economics
About Elgar Research Reviews
Elgar Research Reviews consist of two principal components: a scholarly Review Article and a list of Recommended Readings.
The Review Article prepared by a leading scholar introduces the relevant field of academic study by making reference to the seminal and most transformative articles within that field. This piece sets in context the readings that follow, illustrating how they have shaped the scholarship and why they are important to the development of the field. The Recommended Readings have full references to facilitate further research.
Using the reference links provided
If your library has provided their library link resolver location then we have included a hyperlink under each reference to allow you to search for the article in your library catalogue.
There is also a link to search for each reading in Google Scholar, providing you with an alternative route to find the article on the original publisher’s site and to help you identify similar papers.
Finding a print version of the recommended readings
A print edition of this resource, which also includes the full text of the Recommended Readings in their original layout is available as a single print work, Pharmaceutical Economics, edited by William S. Comanor and Stuart O. Schweitzer (ISBN 978 0 85793 449 9). Use the Find This Book In Your Library button at the top of this page to see if it is available in your library. (The button only appears if your library has provided their link resolver details.)